Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • America Mortgages Now Offers Multifamily Real Estate Loans for Foreign Nationals and U.S. Expats
    America Mortgages Now Offers Multifamily Real Estate Loans for Foreign Nationals and U.S. Expats World News
  • Key Trend Transformation in the Learning Management System (LMS) Market 2025
    Key Trend Transformation in the Learning Management System (LMS) Market 2025 World News
  • Close Calls and the New York Times: What You Need to Know
    Close Calls and the New York Times: What You Need to Know Aviation
  • Illarionov-Nemirya 2023-12-29: The Only Winning Strategy
    Illarionov-Nemirya 2023-12-29: The Only Winning Strategy World News
  • Nuiva brings the power of AI to life in real solutions
    Nuiva brings the power of AI to life in real solutions World News
  • A Sustainable Solution for Eco-Friendly Transportation
    A Sustainable Solution for Eco-Friendly Transportation Business
  • SCOTUS Declines to Hear Libertarian and Green Parties’ Case, May Threaten Third Party Ballot Access in New York State
    SCOTUS Declines to Hear Libertarian and Green Parties’ Case, May Threaten Third Party Ballot Access in New York State Business
  • Private Hospital Market Size, Share, Revenue, Trends And Drivers For 2024-2033
    Private Hospital Market Size, Share, Revenue, Trends And Drivers For 2024-2033 Business
Envision Pharma Group Acquires OKRA.ai

Envision Pharma Group Acquires OKRA.ai

Posted on February 7, 2023 By NewsEditor
Envision Pharma Group Acquires OKRA.aiEnvision Pharma Group Acquires OKRA.aiPivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.

PHILADELPHIA, February 7, 2023 (Newswire.com) - Envision Pharma Group (Envision), a leading global technology-enabled commercialization, integrated medical capabilities and solutions, and data analytics partner to the life sciences industry, announced today it has acquired OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions with present brains across commercialization, real-world evidence and data analytics, medical, and pricing for the pharmaceutical and life sciences industry. 

OKRA.ai's AI products and solutions translate large clinical, scientific, and commercial data sets into actionable insights to empower decision-making and drive action to clients in the life sciences industry.

"We are delighted to welcome OKRA.ai into the Envision Pharma Group family," shares Meg Heim, CEO, Envision Pharma Group. "The acquisition of OKRA.ai marks an exciting milestone in Envision's evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients. The combination of Envision's leading technology, capabilities, and solutions with OKRA.ai's artificial intelligence solutions and expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly, support patients in their journey to health and wellness."  

Dr. Loubna Bouarfa, founder of OKRA.ai, will be joining Envision as a member of its Executive Leadership Team. Recently, Loubna won the prestigious Deloitte Fast 50 Women in Leadership Award and Forbes 50 Top Women in Tech. Loubna shares, "Today is a redefining moment for OKRA.ai. I am honored to be joining forces with Envision and see enormous opportunities for the growth of our combined expertise and solutions for clients in the life sciences industry. As part of Envision Pharma Group, we can accelerate our work to bring AI to the heart of decision-making across the life sciences industry. Our success will not only bring commercial benefit to clients but lead to improved patient outcomes across the globe." 

Based in the U.K. and Netherlands, OKRA.ai employs around 30 members of staff. The acquisition of OKRA.ai will bring the total number of Envision Pharma Group to 1,400+ employees across four continents.  

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product lifecycle through a comprehensive suite of services and industry-leading technology solutions: including evidence-based scientific communications and engagement; commercialization and integrated medical consultancy; and HEOR/market access and data analytics capabilities. Learn more at www.envisionpharmagroup.com

About OKRA.ai 
OKRA.ai is a pioneer in developing AI solutions for the life sciences industry, bringing self-learning AI to optimize commercial, medical and market access decision making. Through its product portfolio, OKRA.ai delivers AI solutions to empower pharmaceutical companies with predictions and suggestions to bring novel treatments to patients in an efficient and effective way. 

OKRA.ai was founded by Dr. Loubna Bouarfa in 2015 with a vision of moving the healthcare industry towards data-driven decision-making by explainable AI. Since then, OKRA.ai has been instrumental in building industry-first Explainable AI which empowers users by providing explanations behind predictions and suggestions. OKRA.ai currently consists of a highly qualified workforce across the UK and the Netherlands and has a nearly equal gender balance (48% of staff are female). 

OKRA.ai's solution suite compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics. Since 2015, OKRA.ai has supported the commercialization of 92 molecules, 67 indications and 13 pharmaceutical brands.

Contact Information:
Colleen Carter
Communications
[email protected]
1 (203) 480 0080


Original Source: Envision Pharma Group Acquires OKRA.ai Envision Pharma Group Acquires OKRA.ai
Business

Post navigation

Previous Post: Under Secretary Zeya’s Travel to Ulaanbaatar, Mongolia and Tokyo, Japan
Next Post: General Communication Equipment Market Size, Share And Growth Analysis For 2023-2032

Related Posts

  • BeachLife Festival 2024 Announces Set Times and Reveals Onsite Activations, Fan Engagements, Giveaways & More
    BeachLife Festival 2024 Announces Set Times and Reveals Onsite Activations, Fan Engagements, Giveaways & More Business
  • Elevating Connectivity with CVM and ICP in Blockchain V1
    Elevating Connectivity with CVM and ICP in Blockchain V1 Business
  • Augmenta AgTech and Torgerson’s LLC Announce Their Partnership
    Augmenta AgTech and Torgerson’s LLC Announce Their Partnership Business
  • ENTEXS Corporation Launches the CWE-Series of Cold-Water Extraction Systems at MJBIZCON, Las Vegas
    ENTEXS Corporation Launches the CWE-Series of Cold-Water Extraction Systems at MJBIZCON, Las Vegas Business
  • How Burglars Choose Homes to Target
    How Burglars Choose Homes to Target Business
  • Clear Ocean Group Sets New Sales Record in Caribe Plaza, San Juan
    Clear Ocean Group Sets New Sales Record in Caribe Plaza, San Juan Business
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • FiniteNow Introduces Instant AI Proposals for Complex Simulation ProjectsOctober 30, 2025
  • Demand for Gene Therapy For Parkinson’s Disease Market is forecasted to reach a value of US $1.62 billion by 2029October 29, 2025
  • Europe Conipack Pails Market to Reach USD 3.3 billion by 2035October 29, 2025
  • Baucor Strengthens Industry Leadership by Expanding Its Product Line in Industrial Cutting and CNC Machining SolutionsOctober 28, 2025
  • War in Ukraine, Analytics. Day 1327: Why Zelensky Is Meeting With Trump. Arestovych, Shelest.October 28, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • War Day 335: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 335: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Dr. Vanessa Victor-Linkenhoker Reveals New Weight Management Techniques in Her Book, Presented by Atticus Publishing
    Dr. Vanessa Victor-Linkenhoker Reveals New Weight Management Techniques in Her Book, Presented by Atticus Publishing World News
  • War Day 40 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych
    War Day 40 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych World News
  • Six original oil paintings by Canadian folk artist Maud Lewis (1903-1970) will headline Miller & Miller auction, Feb. 11
    Six original oil paintings by Canadian folk artist Maud Lewis (1903-1970) will headline Miller & Miller auction, Feb. 11 World News
  • How CBD Helped Save the Life of Stirling CBD’s Founder
    How CBD Helped Save the Life of Stirling CBD’s Founder Business
  • JCG Tax & Advisory Celebrates 10 Years of Excellence and Expansion
    JCG Tax & Advisory Celebrates 10 Years of Excellence and Expansion Business
  • JD Howlette Law files federal civil rights lawsuit against The City of Mt. Rainier and Prince George’s County
    JD Howlette Law files federal civil rights lawsuit against The City of Mt. Rainier and Prince George’s County Business
  • JJ Builders recognized by national guild for excellence in Amish craftsmanship
    JJ Builders recognized by national guild for excellence in Amish craftsmanship Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .